| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 06/21/2005 | US6908927 Reduction physical cigarette smoking |
| 06/21/2005 | US6908915 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/16/2005 | WO2005054249A1 Novel compounds |
| 06/16/2005 | WO2005037832A3 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
| 06/16/2005 | US20050131220 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides |
| 06/16/2005 | US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 06/16/2005 | US20050130976 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | US20050130943 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | DE10353328A1 New naphthalene-1,8-dicarboxylic monoimides for use as sole light stabilizer to protect organic material, e.g. plastics, polymer dispersions, paints and photographic emulsions, from damaging effects of light |
| 06/16/2005 | CA2547547A1 Diazabicyclononene derivatives and their use as renin inhibitors |
| 06/16/2005 | CA2546117A1 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 06/16/2005 | CA2541691A1 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 06/15/2005 | EP1541560A1 Novel tetrahydroquinoline derivatives |
| 06/15/2005 | EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 06/15/2005 | EP1541146A1 Zolpidem hemitartrate solvate |
| 06/15/2005 | EP1539753A2 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors |
| 06/15/2005 | EP1539703A1 Method for the selective preparation of 3-oxo-4-aza-5a-androstane compound |
| 06/15/2005 | EP1539166A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 06/15/2005 | EP1539164A1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 06/15/2005 | EP1539150A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 06/15/2005 | EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/15/2005 | CN1626534A Steroid receptor modulator compounds and methods |
| 06/15/2005 | CN1206221C Acridine derivatives |
| 06/14/2005 | US6906193 N-type calcium channel antagonists for the treatment of pain |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | CA2163122C Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 06/09/2005 | WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051317A2 Substituted imidazo ring systems and methods |
| 06/09/2005 | WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124652 Guanidino compounds |
| 06/09/2005 | US20050124643 Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 06/09/2005 | CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier |
| 06/09/2005 | CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545659A1 Bicyclic inhibitors of mek |
| 06/08/2005 | EP1537110A2 Triazospiro compounds having nociceptin receptor affinity |
| 06/08/2005 | EP1537086A2 Novel phenanthridines |
| 06/08/2005 | EP1536798A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 06/08/2005 | EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 06/07/2005 | US6903109 Arylindenopyridines and related therapeutic and prophylactic methods |
| 06/07/2005 | US6903094 As analgesic |
| 06/02/2005 | WO2005005606A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 06/02/2005 | WO2005005380A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 06/02/2005 | CA2546028A1 Novel compounds |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534682A1 Novel molecules derived from noraporphine |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same |
| 05/31/2005 | US6900322 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 05/31/2005 | US6900228 Analgesics; side effect reduction |
| 05/26/2005 | WO2005047265A1 Use of 4-cyano-naphthalene-1, 8-dicarboximide derivatives and related compounds to protect organic material from the damaging effects of light |
| 05/26/2005 | WO2005047258A2 Methods and compositions for selectin inhibition |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005030791A3 Isoquinolinone potassium channel inhibitors |
| 05/26/2005 | WO2004063164A8 Process for the preparation of aryl fused polycyclic lactams |
| 05/26/2005 | US20050113579 Antitumor agents; formed by refluxing mixture of amonafide with acetic acid |
| 05/26/2005 | CA2544247A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/26/2005 | CA2543765A1 Methods and compositions for selectin inhibition |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 05/25/2005 | EP1531816A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 05/25/2005 | EP1056724B1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 05/25/2005 | CN1620430A 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/24/2005 | US6897317 For therapy of arteriosclerosis and dyslipidaemias |
| 05/24/2005 | US6897310 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | CA2174000C Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107415 Opioid and opioid-like compounds and uses thereof |
| 05/19/2005 | US20050107402 4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/18/2005 | CN1616472A Process for preparing caulopyhllum robustum total alkali |
| 05/18/2005 | CN1616431A Huperzine B bimolecular and double function group devicative, preparing method and its use |
| 05/18/2005 | CN1616430A Rosinyl acridine its producing method and use thereof |
| 05/18/2005 | CN1616429A Red light emitting naphthyl imide compound and its synthetic method |
| 05/17/2005 | US6894191 Reacting arylamine with aromatic halide in presence of catalyst and base |
| 05/17/2005 | US6894061 Substituted dihydrophenanthridinesulfonamides |
| 05/17/2005 | US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 05/12/2005 | WO2005042500A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| 05/12/2005 | WO2004096802A3 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
| 05/12/2005 | US20050101590 Cannabinoid receptor agonists |
| 05/12/2005 | US20050101569 Methods and compositions for selectin inhibition |
| 05/12/2005 | CA2540881A1 Thieno-pyridinone derivatives as kinase inhibitors |
| 05/12/2005 | CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| 05/11/2005 | EP1147087B1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 05/10/2005 | US6891057 Compounds for generating chemiluminescence with a peroxidase |
| 05/10/2005 | US6890936 Muscarinic antagonists |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/10/2005 | US6890377 Absorb in the red and infrared region of the electromagnetic spectrum |
| 05/10/2005 | CA2250569C Novel phenanthridines substituted in the 6 position |
| 05/06/2005 | WO2005009949A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |